Could eating all your meals before 3 PM and exercising strengthen bones and prevent falls in older age?

NCT ID NCT07695961

First seen Jul 10, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study investigates whether combining early time-restricted eating (eating all daily food within an 8-hour window, e.g., 7 AM to 3 PM) with a structured exercise program can improve bone density, walking, balance, and reduce fall risk in healthy adults aged 60 and older. About 44 participants will follow the diet-exercise plan or continue their usual lifestyle for 6 months. The goal is to see if this lifestyle approach can help maintain musculoskeletal health and independence in older age.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
early time-restricted eating (16:8 schedule) plus multicomponent exercise
What this could lead to
If successful, this combination could offer a simple, non-drug way to strengthen bones, improve balance, and reduce fall risk in older adults.
What could go wrong
The trial is small (44 participants) and lasts only 6 months, so results may not apply to everyone or show lasting benefits. Adherence to the eating schedule may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intermittent Fasting nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Manouba University

    Manouba, Manouba, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.